-+ 0.00%
-+ 0.00%
-+ 0.00%

Korea Pharma enters KRW 1 billion treasury stock buyback trust contract

PUBT·10/02/2026 02:52:46
Listen to the news
Korea Pharma enters KRW 1 billion treasury stock buyback trust contract
  • Korea Pharma set a KRW 1 billion trust buyback to acquire up to 133,333 shares, based on a reference price of KRW 7,500.
  • Trust term runs from Oct. 6, 2026 to Apr. 6, 2027, with NH Investment & Securities as trustee.
  • Stated purpose: boost shareholder value, support employee stock option payments.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Korea Pharma Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261002000123), on October 02, 2026, and is solely responsible for the information contained therein.